The DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–245 of 245
Handbook of Clinical alcoholism Treatment
Trevino, J. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1220b · Cited by 51
Naloxone attenuation of voluntary alcohol consumption.
Froehlich, J. C., Hurley, J. H., Lumeng, L., & Li, T. (1987) · PubMed · Cited by 51
Overstreet, D. H., McArthur, R. A., Rezvani, A. H., & Post, C. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199711000-00015 · Cited by 51
Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol
Roberts, A. J., McArthur, R. A., Hull, E. E., Post, C., & Koob, G. F. (1998) · Psychopharmacology · doi:10.1007/s002130050589 · Cited by 50
de Witte, P. A. M. (2008) · Neuropsychobiology · doi:10.1159/000118113 · Cited by 49
Effects of Topiramate on Ethanol and Saccharin Consumption and Preferences in C57BL/6J Mice
Gabriel, K. I., & Cunningham, C. L. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150014.79657.64 · Cited by 48
INTERACTIONS BETWEEN CANNABINOID AND OPIOID RECEPTOR SYSTEMS IN THE MEDIATION OF ETHANOL EFFECTS
Manzanares, J., Ortiz, S., Oliva, J. M., Pérez-Rial, S., & Palomo, T. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh112 · Cited by 48
Acamprosate in Relapse Prevention of Alcoholism
(1996) · Springer eBooks · doi:10.1007/978-3-642-80193-8 · Cited by 48
Galloway, G. P., Koch, M., Cello, R., & Smith, D. E. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-18 · Cited by 47
Suppression of Alcohol Preference in High Alcohol Drinking Rats
Myers, R. D., & Lankford, M. F. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00081-n · Cited by 47
Apomorphine and 7-OH DPAT reduce ethanol intake of P and HAD rats
Russell, R., McBride, W. J., Lumeng, L., Li, T., & Murphy, J. M. (1996) · Alcohol · doi:10.1016/0741-8329(95)00062-3 · Cited by 47
Doty, P., & de Wit, H. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199506000-00009 · Cited by 46
Fluoxetine suppresses palatability-induced ingestion
Leander, J. D. (1987) · Psychopharmacology · doi:10.1007/bf00518178 · Cited by 46
Kotlinska, J. H., Bochenski, M., & Danysz, W. (2005) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000181600.95405.c7 · Cited by 45
Farook, J. M., Morrell, D. J., Lewis, B., Littleton, J. M., & Barron, S. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm047 · Cited by 45
The Neurobiology of Motivation and Reward
Boddy, J. (1986) · Biological Psychology · doi:10.1016/0301-0511(86)90025-6 · Cited by 44
Drugs for Relapse Prevention of Alcoholism
Spanagel, R., & Mann, K. F. (2005) · Birkhäuser Basel eBooks · doi:10.1007/b137043 · Cited by 44
Lallemand, F., & Witte, P. D. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.08.001 · Cited by 43
Lack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats
Magnen, J. L., Tran, G., & Durlach, J. (1987) · Alcohol · doi:10.1016/0741-8329(87)90006-1 · Cited by 43
Bolo, N. R., Nédélec, J.-F., Muzet, M., Witte, P. D., Dahchour, A., Durbin, P., & Macher, J. P. (1998) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(98)00017-1 · Cited by 40
Dyr, W., & Kostowski, W. (1995) · Alcohol · doi:10.1016/0741-8329(95)00023-k · Cited by 40
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Escher, T., & Mittleman, G. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00004.x · Cited by 39
Wiesbeck, G. A., Weijers, H. ‐., Chick, J., Naranjo, C. A., Boening, J., & Behalf of the Ritanserin in Alcoholism Work Group (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04105.x · Cited by 39
Isolation and striatal (3H) serotonin uptake: Role in the voluntary intake of ethanol by rats
Daoust, M., Chrétien, P., Moore, N. D., et al. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90378-8 · Cited by 37
Topiramate reduces the harm of excessive drinking: implications for public health and primary care
Ma, J. Z., Ait‐Daoud, N., & Johnson, B. A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01576.x · Cited by 37
Self-citationSilverstone, T. (1982) · Cited by 36
Colombo, G., Serra, S., Vacca, G., Gessa, G. L., & Carai, M. A. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.03.065 · Cited by 34
Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism?
Nagy, J. (2004) · PubMed · Cited by 34
Handbook of clinical alcoholism treatment
Johnson, B. A., Ruiz‐Esteban, P., & Galanter, M. S. (2003) · Cited by 33
Self-citationMatsuzawa, S., Suzuki, T., Misawa, M., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00144-7 · Cited by 32
Effects of ondansetron pretreatment on acute responses to ethanol in social drinkers
Doty, P., Zacny, J. P., & de Wit, H. (1994) · Behavioural Pharmacology · doi:10.1097/00008877-199408000-00007 · Cited by 28
Alcohol‐induced reinforcement: Dopamine and 5‐HT3 receptor interactions in animals and humans
Johnson, B. A., & Cowen, P. J. (1993) · Drug Development Research · doi:10.1002/ddr.430300308 · Cited by 27
Self-citationMason, G., Rezvani, A. H., Grady, D. R., & Garbutt, J. C. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00104.x · Cited by 27
Zalewska-Kaszubska, J., Górska, D., Dyr, W., & Czarnecka, E. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.028 · Cited by 27
Effects of pre-feeding on food-approach latency and food consumption speed in food deprived rats
Wise, R. A., & Raptis, L. (1985) · Physiology & Behavior · doi:10.1016/0031-9384(85)90266-5 · Cited by 27
Ait‐Daoud, N., Johnson, B. A., Javors, M. A., Roache, J. D., & Zanca, N. A. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02289.x · Cited by 27
Self-citationNaltrexone and Amperozide Modify Chocolate and Saccharin Drinking in High Alcohol-Preferring P Rats
Biggs, T. A. G. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00598-4 · Cited by 24
Alcohol Consumption Is Enhanced After Naltrexone Treatment
Juárez, J., & Eliana, B. D. T. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00313.x · Cited by 24
Actions of Acamprosate on Neurons of the Central Nervous System
Zieglgänsberger, W., Hauser, C., Wetzel, C. H., Putzke, J., Siggins, G. R., & Spanagel, R. (1996) · Springer eBooks · doi:10.1007/978-3-642-80193-8_4 · Cited by 23
New Weapon to Curb Smoking: No More Excuses to Delay Treatment
Johnson, B. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1547 · Cited by 21
Self-citationNeuropeptides and alcohol addiction in monkeys
van Ree, J. M., Kornet, M., & Goosen, C. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7_17 · Cited by 19
Johnson, B. A., Mann, K. F., Willenbring, M. L., Litten, R. Z., Swift, R. M., Lesch, O., & Berglund, M. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000174690.63787.fc · Cited by 19
Self-citationO'Shea, B. (2000) · Hospital Medicine · doi:10.12968/hosp.2000.61.12.1483 · Cited by 14
Witte, P. D., Bachteler, D., & Spanagel, R. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7305-9_7 · Cited by 12
Research works printed but not linked: 30
- Resch, 2005, Glycyl-glutamine in nucleus accumbens reduces ethanol intake in alcohol preferring (P) rats, Brain Res, 1058, 73, 10.1016/j.brainres.2005.07.066 · doi:10.1016/j.brainres.2005.07.066
- Ross, 1976, Ethanol preference in the hamster: effects of morphine sulfate and naltrexone, a long-acting morphine antagonist, Proc West Pharmacol Soc, 19, 326
- Berman, 1984, Effects of naloxone on ethanol dependence in rats, Drug Alcohol Depend, 13, 245, 10.1016/0376-8716(84)90065-6 · doi:10.1016/0376-8716(84)90065-6
- Williams, 2004, Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic–pituitary–adrenal activity in rhesus monkeys, Alcohol Clin Exp Res, 28, 566, 10.1097/01.ALC.0000121655.48922.C4 · doi:10.1097/01.alc.0000121655.48922.c4
- Alim TN, Tai B, Chiang CN, Green T, Rosse RB, Lindquist T, et al. Tolerability study of a depot form of naltrexone substance abusers [abstract]. In: Harris LS, editor. Problems of drug dependence 1994: Proceedings of the 56th annual scientific meeting. vol. II. The College on Problems of Drug Dependence, Inc. NIDA Res Monogr 1995;153:253.
- Heishman SJ, Francis-Wood A, Keenan RM, Chiang CN, Terrill JB, Tai B, et al. Safety and pharmacokinetics of a new formulation of naltrexone [abstract]. In: Harris LS, editor. Problems of drug dependence 1993: Proceedings of the 55th annual scientific meeting. vol. II. The College on Problems of Drug Dependence, Inc. NIDA Res Monogr 1994;141:82.
- Biton, 2001, Topiramate titration and tolerability, Ann Pharmacother, 35, 173, 10.1345/aph.10093 · doi:10.1345/aph.10093 · Paper page
- Geller, 1973, Effects of para-chlorophenylalanine and 5-hydroxytryptophan on alcohol intake in the rat, Pharmacol Biochem Behav, 1, 361, 10.1016/0091-3057(73)90130-5 · doi:10.1016/0091-3057(73)90130-5
- Gill, 1988, A further examination of the effects of sertraline on voluntary ethanol consumption, Alcohol, 5, 355, 10.1016/0741-8329(88)90020-1 · doi:10.1016/0741-8329(88)90020-1
- Maurel, 1999, Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats, Alcohol, 17, 195, 10.1016/S0741-8329(98)00046-9 · doi:10.1016/s0741-8329(98)00046-9
- Gottfries, 1981, Influence of depression and antidepressants on weight, Acta Psychiatr Scand Suppl, 290, 353, 10.1111/j.1600-0447.1981.tb00739.x · doi:10.1111/j.1600-0447.1981.tb00739.x
- Simpson, 1981, Effect of zimelidine, a new antidepressant, on appetite and body weight, Br J Clin Pharmacol, 11, 96, 10.1111/j.1365-2125.1981.tb01112.x · doi:10.1111/j.1365-2125.1981.tb01112.x
- Li, 1983, 5-Hydroxytryptamine control of meal to meal composition chosen by rats, Fed Proc, 42, 542
- Heisler, 1997, Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats, Pharmacol Biochem Behav, 58, 767, 10.1016/S0091-3057(97)00036-1 · doi:10.1016/s0091-3057(97)00036-1
- Haraguchi, 1990, Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine, Pharmacol Biochem Behav, 35, 259, 10.1016/0091-3057(90)90236-B · doi:10.1016/0091-3057(90)90236-b
- Gulley, 1995, Selective serotonin reuptake inhibitors: effects of chronic treatment on ethanol-reinforced behavior in mice, Alcohol, 12, 177, 10.1016/0741-8329(94)00079-S · doi:10.1016/0741-8329(94)00079-s
- Meert, 1993, Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference, Alcohol Alcohol, 28, 157
- Meert, 1991, Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats, Pharmacopsychiatry, 24, 159, 10.1055/s-2007-1014461 · doi:10.1055/s-2007-1014461
- Myers, 1992, Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide, Pharmacol Biochem Behav, 43, 661, 10.1016/0091-3057(92)90392-S · doi:10.1016/0091-3057(92)90392-s
- Myers, 1998, Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats, Pharmacol Biochem Behav, 59, 91, 10.1016/S0091-3057(97)00330-4 · doi:10.1016/s0091-3057(97)00330-4
- Lankford, 1996, Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats, Alcohol, 13, 399, 10.1016/0741-8329(96)00061-4 · doi:10.1016/0741-8329(96)00061-4
- Zhou, 1996, Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells, J Pharmacol Exp Ther, 278, 732
- Lovinger, 1991, Inhibition of 5-HT3 receptor-mediated ion current by divalent metal cations in NCB-20 neuroblastoma cells, J Neurophysiol, 66, 1329, 10.1152/jn.1991.66.4.1329 · doi:10.1152/jn.1991.66.4.1329
- Lovinger, 1991, Ethanol potentiates ion current mediated by 5-HT3 receptors on neuroblastoma cells and isolated neurons, Alcohol Alcohol Suppl, 1, 181
- Bradbury, 1985, Laterality of dopamine function and neuroleptic action in the amygdala in the rat, Neuropharmacology, 24, 1163, 10.1016/0028-3908(85)90149-2 · doi:10.1016/0028-3908(85)90149-2
- Eison, 1982, Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions, Science, 215, 188, 10.1126/science.6171884 · doi:10.1126/science.6171884
- Rodd-Henricks, 1999, Intracranial self-administration of ethanol into the posterior VTA of Wistar rats is mediated by 5-HT3 receptors [abstract], Alcohol Clin Exp Res, 23, 49A
- Sellers, 1992, Serotonin and alcohol drinking, NIDA Res Monogr, 119, 141
- Beardsley, 1994, Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats, Alcohol, 11, 389, 10.1016/0741-8329(94)90023-X · doi:10.1016/0741-8329(94)90023-x
- Naranjo, 1992, Novel neuropharmacological treatments of alcohol dependence, Clin Neuropharmacol, 15, 74A, 10.1097/00002826-199201001-00040 · doi:10.1097/00002826-199201001-00040
Cited by
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
A clinical perspective of obesity, metabolic syndrome and cardiovascular disease
Han, T. S., & Lean, M. E. (2016) · JRSM Cardiovascular Disease · doi:10.1177/2048004016633371 · Cited by 500
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 498
Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503
Dopaminergic reward system: a short integrative review
Arias-Carrión, O., Stamelou, M., Murillo-Rodríguez, E., Menéndez-González, M., & Pöppel, E. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-24 · Cited by 416
Metadata
- Authors
- Johnson, B. A.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 75
- Issue
- 1
- Pages
- 34-56
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2082206299
- Cited by
- 264
- References
- 245
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.